Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials

@article{Fogacci2019EffectOR,
  title={Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials},
  author={Federica Fogacci and Giuliano Tocci and Vivianne Presta and Andrea Fratter and Claudio Borghi and Arrigo Francesco Giuseppe Cicero},
  journal={Critical Reviews in Food Science and Nutrition},
  year={2019},
  volume={59},
  pages={1605 - 1618}
}
ABSTRACT Introduction: Results of previous clinical trials evaluating the effect of resveratrol supplementation on blood pressure (BP) are controversial. Purpose: We aimed to assess the impact of resveratrol on BP through systematic review of literature and meta-analysis of available randomized, controlled clinical trials (RCTs). Methods: Literature search included SCOPUS, PubMed-Medline, ISI Web of Science and Google Scholar databases up to 17th October 2017 to identify RCTs investigating the… Expand
The Effects of Resveratrol Supplementation on Endothelial Function and Blood Pressures Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
TLDR
Resveratrol supplementation significantly increased FMD among patients with MetS and related disorders, but did not affect SBP and DBP. Expand
Resveratrol supplementation significantly influences obesity measures: a systematic review and dose–response meta‐analysis of randomized controlled trials
TLDR
The data suggest that resveratrol supplementation has beneficial effects to reduce BW, BMI and WC, but not FM, while those with long‐term interventions performed on people with obesity. Expand
Effects of resveratrol supplementation on bone biomarkers: a systematic review and meta‐analysis
TLDR
It is indicated that resveratrol supplementation increased some key bone biomarkers, such as ALP and BAP, and further precise clinical trials of the effects of resver atrol supplementation on bone health should be conducted. Expand
Effect of proanthocyanidins on blood pressure: A systematic review and meta-analysis of randomized controlled trials.
TLDR
It is suggested that PCs supplementation may be a useful treatment of hypertensive patients as well as a preventive measure in the prehypertensive and healthy subjects, however, further investigation is needed to confirm these results. Expand
Effect of Pycnogenol on Blood Pressure: Findings From a PRISMA Compliant Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled, Clinical Studies
TLDR
A systematic review of literature and meta-analysis of available randomized, double-blind, placebo-controlled clinical studies investigating the effect of pycnogenol supplementation on blood pressure found no significant effect. Expand
Metabolic effect of berberine–silymarin association: A meta‐analysis of randomized, double‐blind, placebo‐controlled clinical trials
TLDR
The present findings suggest that the coadministration of berberine and silymarin is associated with an advantageous improvement in lipid and glucose profile, suggesting the possible use of this nutraceutical combination in order to promote the cardiometabolic health. Expand
Efficacy and Safety of Resveratrol Supplements on Blood Lipid and Blood Glucose Control in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  • Tianqing Zhang, Qi He, Yao Liu, Zhenrong Chen, Hengjing Hu
  • Medicine
  • Evidence-based complementary and alternative medicine : eCAM
  • 2021
TLDR
Based on the current evidence, resveratrol may improve insulin resistance, lower fasting blood glucose and insulin levels, and improve oxidative stress in patients with type 2 diabetes mellitus. Expand
A Meta-Analysis of the Impact of Resveratrol Supplementation on Markers of Renal Function and Blood Pressure in Type 2 Diabetic Patients on Hypoglycemic Therapy
TLDR
In all, resveratrol supplementation in hypoglycemic therapy improves glucose control and lowers blood pressure; however, additional evidence is necessary to confirm its effect on renal function in patients with T2D. Expand
The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials.
TLDR
Current evidence does not support supplementation with resveratrol for the management of cardiometabolic risk factors in patients with T2D, MetS, and NAFLD. Expand
Nutraceuticals and Hypertensive Disorders in Pregnancy: The Available Clinical Evidence
TLDR
There is a relative body of evidence that supports the use of calcium, vitamin D, folic acid, and resveratrol in preventing the development of hypertensive disorders in pregnancy, and evidence supporting drug treatment too. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 53 REFERENCES
Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials.
TLDR
The present meta-analysis indicates that resveratrol consumption significantly decreases the SBP level at the higher dose, while resver atrol has no significant effects on DBP levels. Expand
Effects of Quercetin on Blood Pressure: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
TLDR
The results of the meta‐analysis showed a statistically significant effect of quercetin supplementation in the reduction of BP, possibly limited to, or greater with dosages of >500 mg/day. Expand
Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors--Results from a systematic review and meta-analysis of randomized controlled trials.
TLDR
A meta-analysis of available RCTs does not suggest any benefit of resveratrol supplementation on CV risk factors, and larger, well-designed trials are necessary to confirm these results. Expand
Nutraceuticals with a clinically detectable blood pressure-lowering effect: a review of available randomized clinical trials and their meta-analyses.
TLDR
Some nutraceuticals might have a positive impact on BP in humans, and a relatively large body of evidence supports the use of potassium, magnesium, L-arginine, vitamin C, cocoa flavonoids, beetroot juice, coenzyme Q10, controlled-release melatonin and aged garlic extract. Expand
Effect of pistachio on brachial artery diameter and flow-mediated dilatation: A systematic review and meta-analysis of randomized, controlled-feeding clinical studies
TLDR
The present meta-analysis suggests a significant effect of pistachio on ER, affecting BAD but not FMD, suggesting a significant change in brachial artery flow-mediated dilatation following pistachios consumption. Expand
Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis
TLDR
Evidence is provided that supplementation of resveratrol may benefit management of type 2 diabetes mellitus and that the latter dose presented more favorable results. Expand
Lipid-lowering activity of artichoke extracts: A systematic review and meta-analysis
TLDR
Benefit of supplementation with artichoke extract was associated with a significant reduction in both total and LDL-C, and triglycerides, suggesting that supplementation may be synergistic with lipid-lowering therapy in patients with hyperlipidemia. Expand
No Beneficial Effects of Resveratrol on the Metabolic Syndrome: A Randomized Placebo-Controlled Clinical Trial
TLDR
RSV treatment did not improve inflammatory status, glucose homeostasis, blood pressure, or hepatic lipid content in middle-aged men with MetS, and RSVhigh significantly increased total cholesterol, LDL cholesterol, and fructosamine levels compared with placebo. Expand
Effect of extended-release niacin on plasma lipoprotein(a) levels: A systematic review and meta-analysis of randomized placebo-controlled trials.
TLDR
In this meta-analysis of randomized placebo-controlled clinical trials, treatment with nicotinic acid was associated with a significant reduction in Lp(a) levels. Expand
Resveratrol Does Not Influence Metabolic Risk Markers Related to Cardiovascular Health in Overweight and Slightly Obese Subjects: A Randomized, Placebo-Controlled Crossover Trial
TLDR
150 mg of daily resveratrol intake for 4 weeks does not change metabolic risk markers related to cardiovascular health in overweight and slightly obese men and women and effects on glucose metabolism warrant further study. Expand
...
1
2
3
4
5
...